New drug combo shows promise for elderly myeloma patients
NCT ID NCT02302495
First seen Jan 10, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tested a combination of three drugs (carfilzomib, melphalan, and prednisone) in 32 elderly patients (65 years or older) with newly diagnosed multiple myeloma, a type of blood cancer. The goal was to find the safest dose of carfilzomib and see how well the combination works at shrinking the cancer. The treatment is not a cure, as multiple myeloma typically requires ongoing management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CH Francilien
Corbeil-Essonnes, 91106, France
-
CH Louis Pasteur
Colmar, 68024, France
-
CH Meaux
Meaux, 77104, France
-
CHRU, Hôpitaux de Brabois
Vandœuvre-lès-Nancy, 54511, France
-
CHRU, Hôtel Dieu
Nantes, 44035, France
-
CHU Henri Mondor
Créteil, 94010, France
-
CHU Nimes CAREMEAU
Nîmes, 30029, France
-
CHU de Limoges
Limoges, 87000, France
-
Centre Hospitalier H. Duffaut
Avignon, 84902, France
-
Centre Hospitalier Lyon Sud -1
Pierre-Bénite, 69495, France
-
Centre Hospitalier William Morey
Chalon-sur-Saône, 71100, France
-
Centre Hospitalier de Chambery
Chambéry, 73011, France
-
Centre Hospitalier de la côte basque
Bayonne, 64109, France
-
Centre Jean Bernard
Le Mans, 72000, France
-
Centre de NICE 2/ Hôpital Archet
Nice, 06202, France
-
Centre hospitalier départemental La Roche sur Yon
La Roche-sur-Yon, 85025, France
-
Chru Lille
Lille, 59037, France
-
Groupe hospitalier Pitié Salpétrière
Paris, 75651, France
-
Hopital J Monod
Montivilliers, 76290, France
-
Hématologie Clinique, CHU, Hôpital d'Enfants
Dijon, 21000, France
-
Hématologie Clinique, Hôpital Robert Debré, CHU Reims
Reims, 51092, France
-
Hématologie, IUCT oncopole
Toulouse, 31059, France
-
Hématologie, Institut Paoli Calmette
Marseille, 13273, France
-
Hôpital E Muller
Mulhouse, 68100, France
-
Hôpital Haut-Leveque
Pessac, 33604, France
-
Hôpital Jean Minjoz
Besançon, 25030, France
-
Hôpital Notre Dame de Bon Secours
Metz, 57038, France
-
Hôpital St Antoine
Paris, 75571, France
-
Hôpital St Antoine Béclére
Clamart, 92140, France
-
Hôpital St Vincent de Paul - GH-ICL
Lille, 59020, France
-
Institut Bergonie
Bordeaux, 33076, France
-
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, 33300, France
-
Unité de Recherche Clinique - CH Perigueux
Périgueux, 24019, France
Conditions
Explore the condition pages connected to this study.